An international study shows that long-term treatment with abatacept is safe and effective in juvenile idiopathic arthritis.
Rita Baron-Faust, MPH
Clazakizumab, with or without methotrexate, was well tolerated and achieved significant improvements in disease activity, in patients with rheumatoid arthritis in this Phase IIb study.
Responses to the combination therapy in this phase 3 clinical trial were seen as early as one week into the study.
Improvements were seen in some patients participating in a phase 3 clinical trial as quickly as 4 weeks after the first treatment.
The news from phase 3 trials of psoriatic arthritis treatments is upbeat: certolizumab pegol (Cimzia), apremilast (Otezla), and secukinumab (Cosentyx) all continue to show positive effects.
Intensive treatment with statins may help reduce risk of cardiovascular events in patients with inflammatory arthritis, suggests a new study.
How do patients with rheumatoid arthritis rate their health and well being? Their relationship with their physician? Two new surveys shed light.
Should you immunize your patients with rheumatoid arthritis against viral infections that could pose a danger to their health?
US Supreme Court has upheld tax subsidies for low income and middle class people who buy health insurance through federal exchanges under the Affordable Care Act. Here's what it means for patients with rheumatologic disease.
Patients with psoriatic arthritis achieve significant improvements in signs and symptoms with the interleukin-12/23 inhibitor ustekinumab (Stelara), and they maintain those gains for 2 years, according to final results from 3 major clinical trials.